| Performance comparison of four exome capture systems for deep sequencing CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ... BMC genomics 15, 1-14, 2014 | 209 | 2014 |
| AZD4573 is a highly selective CDK9 inhibitor that suppresses MCL-1 and induces apoptosis in hematologic cancer cells J Cidado, S Boiko, T Proia, D Ferguson, SW Criscione, M San Martin, ... Clinical cancer research 26 (4), 922-934, 2020 | 201 | 2020 |
| ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response S Nagarajan, SV Rao, J Sutton, D Cheeseman, S Dunn, EK Papachristou, ... Nature genetics 52 (2), 187-197, 2020 | 144 | 2020 |
| Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer S Shu, HJ Wu, YG Jennifer, R Zeid, IS Harris, B Jovanović, K Murphy, ... Molecular cell 78 (6), 1096-1113. e8, 2020 | 138 | 2020 |
| A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes EK Papachristou, K Kishore, AN Holding, K Harvey, TI Roumeliotis, ... Nature communications 9 (1), 2311, 2018 | 125 | 2018 |
| Phospho-regulation of ATOH1 is required for plasticity of secretory progenitors and tissue regeneration G Tomic, E Morrissey, S Kozar, S Ben-Moshe, A Hoyle, R Azzarelli, ... Cell stem cell 23 (3), 436-443. e7, 2018 | 86 | 2018 |
| EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis G Peluffo, A Subedee, NW Harper, N Kingston, B Jovanović, F Flores, ... Cancer research 79 (16), 4173-4183, 2019 | 55 | 2019 |
| FRA2A Is a CGG Repeat Expansion Associated with Silencing of AFF3 S Metsu, L Rooms, J Rainger, MS Taylor, H Bengani, DI Wilson, ... PLoS Genetics 10 (4), e1004242, 2014 | 54 | 2014 |
| Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA I Hudecova, CG Smith, R Hänsel-Hertsch, CS Chilamakuri, JA Morris, ... Genome research 32 (2), 215-227, 2022 | 47 | 2022 |
| ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors R Kupp, L Ruff, S Terranova, E Nathan, S Ballereau, R Stark, ... Cancer discovery 11 (9), 2216-2229, 2021 | 44 | 2021 |
| Long-range evolutionary constraints reveal cis-regulatory interactions on the human X chromosome M Naville, M Ishibashi, M Ferg, H Bengani, S Rinkwitz, M Krecsmarik, ... Nature communications 6 (1), 6904, 2015 | 35 | 2015 |
| BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes I de Santiago, W Liu, K Yuan, M O’Reilly, CSR Chilamakuri, BAJ Ponder, ... Genome biology 18, 1-17, 2017 | 34 | 2017 |
| Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma R Hanes, I Grad, S Lorenz, EW Stratford, E Munthe, CCS Reddy, ... Oncotarget 7 (34), 54583, 2016 | 26 | 2016 |
| An in silico study: novel targets for potential drug and vaccine design against drug resistant H. pylori C Pasala, CSR Chilamakuri, SK Katari, RM Nalamolu, AR Bitla, ... Microbial pathogenesis 122, 156-161, 2018 | 24 | 2018 |
| ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia J Chen, V Sathiaseelan, A Moore, S Tan, CSR Chilamakuri, ... Blood, The Journal of the American Society of Hematology 137 (26), 3629-3640, 2021 | 23 | 2021 |
| Copy number variants in patients with intellectual disability affect the regulation of ARX transcription factor gene M Ishibashi, E Manning, C Shoubridge, M Krecsmarik, TA Hawkins, ... Human genetics 134, 1163-1182, 2015 | 19 | 2015 |
| Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape M Mangolini, A Maiques-Diaz, S Charalampopoulou, ... Nature Communications 13 (1), 6220, 2022 | 16 | 2022 |
| Epitope-driven common subunit vaccine design against H. pylori strains C Pasala, CSR Chilamakuri, SK Katari, RM Nalamolu, AR Bitla, ... Journal of Biomolecular Structure and Dynamics, 2019 | 16 | 2019 |
| Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor … T Barøy, CSR Chilamakuri, S Lorenz, J Sun, ØS Bruland, O Myklebost, ... PLoS One 11 (9), e0163859, 2016 | 16 | 2016 |
| Modulation of catalytic activity in multi-domain protein tyrosine phosphatases LL Madan, S Veeranna, K Shameer, CCS Reddy, R Sowdhamini, B Gopal PLoS One 6 (9), e24766, 2011 | 15 | 2011 |
